Objectives: Carotid artery stenting (CAS) remains an effective alternative to carotid endarterectomy (CEA) for stroke prevention; however, the long-term durability of CAS remains poorly defined. We performed a 10-year comparative analysis of CEA and CAS to help better evaluate the durability of these procedures.
PC120.
The Natural History of Carotid Occlusion Objectives: Carotid stenosis is an important risk factor for ischemic stroke. The management of asymptomatic carotid stenosis is controversial, with various approaches recommending revascularization with carotid endarterectomy or carotid stent for stenosis of 60% to 99%, revascularization for stenosis >75%, revascularization for high-risk patients only, or intensive modern medical treatment. Few studies have noted the incidence of neurologic events in medically treated patients who progress to carotid occlusion. The aim of this study was to describe the natural history of patients with carotid stenosis that progressed to carotid occlusion and to determine the incidence of a neurologic event in this population.
Methods: Loyola University Medical Center Vascular Lab data from 2011 to 2016 were used to identify patients with internal carotid artery occlusion, and their electronic medical records were reviewed for prior carotid ultrasound imaging, computed tomography angiography, magnetic resonance angiogram, or angiogram that did not show evidence of occlusion. The retrospective natural history of this study population was then recorded, including demographics, comorbidities, and medications. The incidence of a neurologic event, defined as the occurrence of transient ischemic attack or cerebrovascular accident was calculated. Comparisons were then drawn between the carotid occlusion group that suffered a neurologic event and the group that did not during the course of carotid disease progression.
Results: The initial search yielded 379 patients with occlusive carotid disease. Of these, 16 patients (4%) demonstrated progression from asymptomatic carotid stenosis to occlusion. Among these 16 patients, the mean age was 71.8 years, 87.5% were men, 87.5% had hypertension, 50% had diabetes mellitus, 6.3% had a history of atrial fibrillation, 68.8% had a smoking history, 6.3% had a history of deep vein thrombosis or pulmonary embolism, 75% were on aspirin therapy, 25% were on clopidogrel, and 81.3% were on a statin. Seven patients (44%) suffered a transient ischemic attack or cerebrovascular accident. The degree of carotid stenosis present prior to the neurologic event ranged from 1% to 49% (2 patients), 50% to 79% (4 patients), and 80% to 99% (1 patient). There were no significant differences in risk factors between the group that suffered a neurologic event and the group that did not.
Conclusions: Progression to carotid occlusion is uncommon, though the incidence of a neurologic event in patients who do progress may be higher than previously thought. Further studies are needed to determine whether stroke prevention in this population is of significant benefit to warrant surgical intervention.
Author Disclosures: B. Aulivola: Nothing to disclose; P. Crisostomo: Nothing to disclose; P. Halandras: Nothing to disclose; L. T. Qu: Nothing to disclose. Objectives: Thoracic outlet syndrome (TOS) is a complex disease process with continued controversy regarding treatment and surgical approach. Understanding causes of treatment failure improves preoperative risk counseling and development of postoperative treatment pathways. We aimed to classify causes for recurrent symptoms in all patients undergoing first rib resection and anterior scalenectomy for TOS.
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Causes and Treatment of Recurrent Symptoms After First Rib Resection for Thoracic Outlet Syndrome
Methods: At the onset of opening a specialized TOS clinic, a prospective database of all patients evaluated was developed. Patients presenting to the clinic with recurrent symptoms after prior first rib resection and anterior scalenectomy were extracted for review from the database. The type of TOS, patient demographics, prior surgical treatment, length of recurrent symptoms, and personal disability from recurrent symptoms were collected for each patient. Patients were classified by the cause of recurrent symptoms. Treatment and outcomes were compared using descriptive statistics.
Results: Over a 3-year period, 156 patients were evaluated and diagnosed with TOS. Twenty-two patients presented for recurrent symptoms after anterior scalenectomy and first rib resection. Sixteen were treated for neurogenic TOS (nTOS), one for arterial TOS, and five for venous TOS (vTOS). In patients with nTOS, the cause of recurrent symptoms was repeat injury (n ¼ 5), dense scar tissue (n ¼ 10), or residual cervical rib (n ¼ 1). Four patients with vTOS presented with new-onset symptoms including numbness and tingling down the arm into the hand. Three of these were due to residual posterior rib segments, and one was due to extensive scar tissue with calcification along the supraclavicular and infraclavicular incisions. The final patient presented with pain and swelling after subclavian vein stent thrombosis. In both nTOS and vTOS cases where residual rib was present, repeat surgical
